FADS1 and metabolic dysfunction-associated steatohepatitis: A comprehensive lipidomic analysis on human liver biopsies revealed decreased activity of fatty acid desaturase 1 (FADS1) which is a key player in accumulating toxic lipids during NASH progression (91).